By: Naedine Hazell From: yale.ed Yale pathology researchers created a dependable test that precisely measures key proteins found in breast cancer cells that can help oncologists choose the most effective targeted therapies for patients, says a report published July 16 in Precision Oncology, a journal of the American Society of Clinical Oncology. The assay, named Troplex™, was designed to help …
Brain MRI tracks risk of stage IV breast cancer metastases
By: Kate Madden Yee From: auntminnie.com Brain MRI shows promise for surveilling women at risk for asymptomatic stage IV breast cancer metastases by tracking molecular subtypes of the disease, researchers have reported. “[We found that the] highest frequency of brain metastases at baseline was in triple-negative and HER2-positive [human epidermal growth factor receptor 2-positive] breast cancer,” wrote a team led …